Eupatilin inhibits EGF-induced JB6 cell transformation by targeting PI3K

Feng Li1, Ya Tao1, Yan Qiao1

  • 1Department of Pathophysiology, Basic Medical College, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China.

Insights

Eupatilin, a natural compound, inhibits skin cell transformation by targeting Phosphatidylinositol 3-kinases (PI3Ks). This study reveals eupatilin

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Phosphatidylinositol 3-kinases (PI3Ks) are crucial in cell signaling pathways.
  • Aberrant PI3K pathway activation is linked to cancer development and progression.
  • PI3K is a significant target for cancer chemoprevention and chemotherapy.

Purpose of the Study:

  • To investigate the direct molecular targets of eupatilin, a natural flavone, in cancer chemoprevention.
  • To determine if eupatilin can inhibit skin cell transformation.
  • To elucidate the mechanism by which eupatilin exerts its antitumor effects.

Main Methods:

  • Cell proliferation and colony formation assays using JB6 cells.
  • Western blotting to assess PI3K downstream signaling.
  • Computational docking and pull-down assays to identify eupatilin's binding target.
  • Cell cycle analysis.

Main Results:

  • Eupatilin suppressed JB6 cell proliferation and epidermal growth factor-induced colony formation.
  • Eupatilin treatment reduced phosphorylation of PI3K downstream signaling molecules.
  • Eupatilin induced G1 phase cell cycle arrest and downregulated cyclin D1 expression.
  • Computational and experimental assays confirmed eupatilin binds to the p110α catalytic subunit of PI3K.

Conclusions:

  • Eupatilin demonstrates potential as a chemopreventive agent against skin cell transformation.
  • The mechanism involves targeting and inhibiting the PI3K pathway.
  • Eupatilin's direct binding to PI3K's p110α subunit underlies its observed effects.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.6K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K